首页 | 本学科首页   官方微博 | 高级检索  
     

恶性肿瘤植入放射性125I粒子出现迁移的研究现状与展望
引用本文:朱俊军,葛乃建,杨业发. 恶性肿瘤植入放射性125I粒子出现迁移的研究现状与展望[J]. 中国癌症杂志, 2021, 31(4): 257-262. DOI: 10.19401/j.cnki.1007-3639.2021.04.003
作者姓名:朱俊军  葛乃建  杨业发
作者单位:海军军医大学第三附属医院东方肝胆微创介入中心,上海 201805
基金项目:国家自然科学基金(31971249)。
摘    要:癌症是严重危害人类健康的疾病之一,其发病数和死亡数仍呈持续增加态势,给全球公共卫生系统带来了沉重的负担.在与肿瘤的长期斗争过程中,人们提出了各种各样的方法.100多年前,刚发现伦琴射线不久,人们就开始探索将放射线用于肿瘤的治疗,由此开创了肿瘤放射治疗学.组织间植入放射性粒子治疗肿瘤作为最早开展的近距离放射治疗技术之一,...

关 键 词:恶性肿瘤  近距离放疗  放射性125I  粒子迁移

Current status and prospects of migration of radioactive 125 I seed implanted in malignant tumor
ZHU Junjun,GE Naijian,YANG Yefa. Current status and prospects of migration of radioactive 125 I seed implanted in malignant tumor[J]. China Oncology, 2021, 31(4): 257-262. DOI: 10.19401/j.cnki.1007-3639.2021.04.003
Authors:ZHU Junjun  GE Naijian  YANG Yefa
Affiliation:Eastern Hepatobiliary Intervention Center, the Third Affiliated Hospital of Naval Medical University, Shanghai 201805, China;
Abstract:Cancer is one of the diseases that seriously harm human health. The cancer-related incidence and deaths are still increasing worldwide, which has brought heavy burden to the global public health system. During the long anticancer history, a variety of methods to treat tumors have been developed. More than 100 years ago, shortly after the discovery of Roentgen rays, people began to treat tumors with radiation, and thus pioneered radiation oncology. As a brachytherapy method, implantation of radioactive seeds acts well, has received public recognition, and becomes an important member of the oncology therapeutic spectrum.In vivo, some seeds can migrate from initial site of implantation to other locations. Permanent interstitial brachytherapy and the incidence, mechanism, influence and prevention of 125 I seed migration were reviewed here.
Keywords:Malignant tumor   Brachytherapy  Radioactive   125 I  Seed migration  
点击此处可从《中国癌症杂志》浏览原始摘要信息
点击此处可从《中国癌症杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号